Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Recurrent Melanoma (Skin): early-phase trial registry

1 of 1 indexed Recurrent Melanoma (Skin) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Recurrent Melanoma (Skin): 1 US clinical trial tracked, 1 recruiting.

Recurrent Melanoma (Skin) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Perspective Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition recurrent-melanoma-skin

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Recurrent Melanoma (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Recurrent Melanoma (Skin)

Recurrent Melanoma (Skin) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Recurrent Melanoma (Skin) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Recurrent Melanoma (Skin) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Recurrent Melanoma (Skin) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

[212Pb]VMT01 Drug
1 trials
[203Pb]VMT01 Drug
1 trials
Nivolumab Drug
1 trials

US sites by state

Facility locations filed on Recurrent Melanoma (Skin) trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Pennsylvania 1 trials
Nebraska 1 trials
Missouri 1 trials
Minnesota 1 trials
Kentucky 1 trials
Iowa 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Recurrent Melanoma (Skin) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recurrent Melanoma (Skin) condition card totals 1 registered trials; most-linked intervention [212Pb]VMT01; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.